Publications en collaboration avec des chercheurs de Claude Bernard University Lyon 1 (1)

2021

  1. Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter Study

    Targeted Oncology, Vol. 16, Núm. 4, pp. 485-492